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Abstract
Necrotizing enterocolitis (NEC) is a severe disease of the gastrointestinal tract in premature 
infants, characterized by a disrupted intestinal epithelium and an exaggerated pro-inflammatory 
response. Since the activation of Toll-like receptor-4 (TLR4) blocks cell migration and 
proliferation and contributes to an uncontrolled inflammatory response within the intestine, this 
receptor has been identified as a key contributor to the development of NEC. Toll-like receptor-9 
(TLR9) has been shown to sense bacterial genome components (CpG DNA) and to play an anti-
inflammatory role in NEC. We present in vitro results demonstrating direct inhibition of TLR4 
activation by CpG DNA, and we develop a mathematical model of bacteria–immune interactions 
within the intestine to investigate how such inhibition of TLR4 signaling might alter inflammation, 
associated bacterial invasion of tissue, and resulting outcomes. The model predicts that TLR9 can 
inhibit both the beneficial and detrimental effects of TLR4, and thus a proper balance of action by 
these two receptors is needed to promote intestinal health. The model results are also used to 
explore three interventions that could potentially prevent the development of NEC: reducing 
bacteria in the mucus layer, administering probiotic treatment, and blocking TLR4 activation. 
While the model shows that these interventions would be successful in most cases, the model is 
also used to identify situations in which the proposed treatments might be harmful.
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1. Introduction
Necrotizing enterocolitis (NEC) is a devastating gastrointestinal tract disease that is among 
the leading causes of neonatal mortality (Guner et al., 2009). The disease primarily affects 
premature infants, which in part reflects the immature intestinal barrier function and 
immune/inflammatory responses. In healthy infants, the intestinal epithelial barrier, which 
separates the contents of the intestinal lumen from the blood and tissue, is intact. In infants 
with NEC, a compromised epithelial barrier and immature immune response can lead to 
exaggerated inflammation and bacterial translocation from the intestinal lumen into the 
circulation, potentially resulting in systemic sepsis and subsequent multi-organ failure 
(Hunter et al., 2008).
The gut of the newborn is sterile at birth (Gregory et al., 2011). Immediately following birth, 
the intestinal lumen is colonized with a dense and rapidly diversifying population of 
bacteria, known as the normal flora, that is essential for the maturation of the immune 
system and for the developmental regulation of the intestinal physiology (Collado et al., 
2012). The first components of the normal flora to appear are facultative anaerobes, such as 
enterobacteria, coliforms, lactobacilli, and streptococci; these are typically followed by 
anaerobes, including bifidobacteria, bacteroides, clostridia, and eubacteria. Common 
bifidobacteria include B. infantis, B. longum, and B. breve. The mode of delivery (i.e., 
vaginal or cesarian) as well as nutrition type (i.e., breast fed vs. formula fed) are key factors 
that cause differential colonization and composition of the neonatal gut (Turroni et al., 
2012). Once the normal flora is established in the early years of life, it is thought that this 
composition of flora is not changed throughout the rest of life (Collado et al., 2012). In 
general, the normal flora (also known as commensal bacteria) are beneficial for the host and 
promote health by enhancing digestion efficiency, limiting pathogenic bacterial colonization, 
and triggering the development and maturation of the immune system. Host defense 
mechanisms prevent uncontrolled inflammatory responses to commensal bacteria by 
limiting direct contact between bacteria and the epithelium. Such mechanisms provide 
immune tolerance to commensal bacteria but trigger an immune response to foreign bacterial 
populations (Ohland and MacNaughton, 2010). However, since the composition of 
commensal bacteria populations can vary greatly between helpful and harmful bacteria at 
various times or within different individuals (Hooper and Macpherson, 2010), the host is 
challenged with determining the appropriate response to these microorganisms (Duerkop et 
al., 2009). The mucus layer, intestinal macrophages, and blood macrophages are three 
important defense mechanisms that help to maintain homeostasis in the gut. However, the 
inflammatory response by which macrophages eliminate bacteria also can cause collateral 
tissue damage and must be moderated by anti-inflammatory mechanisms to avoid negative 
outcomes. An ideal balance of these defense mechanisms should protect the host from 
invading pathogens across a broad range of conditions, whereas an imbalance that emerges 
in particular situations, such as in immature states, would result in disease, such as NEC.
Despite the advances that several studies have made to clarify the pathogenesis of NEC, 
there is still uncertainty regarding how specific gastrointestinal components contribute to the 
emergence of this multifactorial disease. Although numerous factors must be considered to 
gain a comprehensive understanding of NEC, studies showing that TLR4 is increased in the 
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bowel of humans with NEC and that TLR4 signaling in the intestinal epithelium is required 
for NEC (Sodhi et al., 2012) have motivated the use of computational modeling in this paper 
to explore how enterocyte Toll-like receptors (TLRs), which are activated by membrane 
components or DNA of bacteria, affect the pathogenesis of NEC. TLR4 molecules sense 
bacteria and release antimicrobial agents that protect against bacterial translocation 
(Kubinak and Round, 2012), but they also promote potentially damaging inflammation. 
Hackam and colleagues have shown that TLR9 molecules suppress TLR4 activation within 
the newborn small intestinal mucosa, potentially reducing inflammatory damage but also 
compromising their antibacterial effects (Gribar et al., 2009; Afrazi et al., 2011; Sodhi et al., 
2011). Computational modeling offers a means to explore how these competing effects 
interact, which long-term outcomes are expected in different parameter regimes, and how 
attempts at therapeutic intervention can influence system dynamics. In the remainder of the 
introduction, we provide some additional background information on biological components 
that are relevant to our model. We present the computational model in Section 2. In Section 
3, we give results on stable steady state solutions of the model, including how these states 
depend on key model parameters. We start with a core model lacking TLR4 or TLR9 and 
subsequently introduce first TLR4 and then TLR9 to the model to illustrate how each of 
these elements contribute to the system’s long-term behavior. The paper concludes with a 
discussion in Section 4.
1.1. Intestinal mucus layer
A layer of mucus lines the apical side of the epithelium in order to prevent direct contact of 
luminal bacteria with epithelial cells. This is the first key barrier that intestinal bacteria 
encounter. The composition of the mucus inhibits effective or rapid movement of bacteria. 
However, in areas of inflammation, the mucus layer tends to be thinner, often allowing 
pathogenic bacteria to penetrate the mucus and reach the epithelium (Corazziari, 2009).
Several antimicrobial proteins, such as defensins and cathelicidins, are released into the 
mucus layer and eliminate bacteria (Duerkop et al., 2009). These proteins are expressed 
constitutively but are also induced in the presence of bacteria. For example, dendritic 
(immune) cells residing in the intestinal tissue can extend protrusions through the epithelial 
layer and sample the bacterial contents of the lumen. If bacteria are sensed, these dendritic 
cells trigger the release of antimicrobial proteins or IgAs. Antimicrobial proteins promote 
bacterial killing by compromising the integrity of bacterial cell walls (Ohland and 
MacNaughton, 2010; Duerkop et al., 2009). Bacteria-specific IgAs are secreted into the 
intestinal lumen, where they trap pathogens by surrounding them with a hydrophilic shell 
that is repelled from the epithelium (Ohland and MacNaughton, 2010; Duerkop et al., 2009; 
Leser and Molbak, 2009). Antimicrobial proteins also target normal microflora in order to 
prevent an unnecessary or harmful inflammatory response in the gut (Meyer-Hoffert et al., 
2008).
1.2. Intestinal and blood macrophages
In some cases, the mucus layer is insufficient to prevent bacterial penetration of the 
intestinal epithelium or inhibit an inflammatory response against commensal bacteria. 
Instead, bacteria (pathogenic or commensal) may enter epithelial cells or pass through 
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spaces between them. Ideally, these bacterial invaders will be eliminated by intestinal 
macrophages, which are macrophages positioned in the intestinal lamina propria that 
respond directly to the presence of bacteria in the intestinal tissue. Intestinal macrophages 
can phagocytose and kill microorganisms but do not release pro-inflammatory cytokines in 
large quantities, unlike macrophages in other tissues (Smith et al., 2005; Smythies et al., 
2005). In this way, bacteria may be eliminated without causing much damage to the gut 
(Smith et al., 2005). However, it is hypothesized that intestinal macrophages are 
dysfunctional in very low birth weight infants, contributing to increased bacterial 
translocation (Sherman, 2010). In particular, in the normal fetus, intestinal macrophages 
undergo progressive inflammatory down-regulation, but in the case of preterm deliveries, 
this down-regulation is incomplete, resulting in an increased risk of a severe inflammatory 
response to bacteria (Maheshwari et al., 2011).
If neither the mucus layer nor intestinal macrophages is effective at preventing bacteria from 
entering the blood and tissue, an overly robust inflammatory response ensues, including the 
activation of blood macrophages and the systemic secretion of pro-inflammatory cytokines. 
An inflammatory response is necessary to destroy harmful bacteria, but inflammation also 
causes injury to the intestinal barrier and inhibits epithelial cell proliferation and migration. 
Thus, as a result of a widespread pro-inflammatory response, the rate of bacterial 
translocation may be increased and the ability to repair the intestinal barrier may be 
impaired.
1.3. TLR4 and TLR9 signaling
TLR4 is expressed on both the apical and basolateral surfaces of enterocytes (intestinal 
epithelial cells) and can facilitate bacterial translocation across the epithelium (Neal et al., 
2006). TLR4 is the main receptor for lipopolysaccharide (LPS), which is a component of the 
outer membrane of Gram-negative bacteria. Gram-negative bacteria are the primary type of 
bacteria that have been identified as being central to the pathogenesis of NEC (Hunter et al., 
2008). If the mucus layer and intestinal macrophage defense mechanisms are not successful 
at preventing bacterial translocation, the activation of TLR4 by LPS can result in a 
widespread pro-inflammatory response. In particular, following TLR4 activation, the nuclear 
factor κ-light-chain-enhancer of activated B cells (NF-κB) is translocated to the nucleus. 
This signaling cascade can trigger the secretion of antimicrobial factors and IgAs (Duerkop 
et al., 2009; Vaishnava et al., 2008) as well as the production and release of various pro-
inflammatory cytokines (Xavier and Podolsky, 2000). If an overwhelming inflammatory 
response occurs, increased damage and bacterial translocation typically result and contribute 
to the development and severity of NEC.
TLR4 expression is significantly elevated in the bowels of humans with NEC (Chan et al., 
2009) and in experimentally induced NEC, relative to control conditions (Leaphart et al., 
2007). If TLR4 is blocked, bacterial translocation is reduced significantly (Neal et al., 2006). 
In fact, Leaphart et al. (2007) observed that in mice whose TLR4 signaling was blocked 
(TLR4-mutant mice, in which the gene coding for TLR4 contains a point mutation that 
nullifies downstream intracellular signaling), there was no response to LPS. Experiments 
have provided a measure of NEC severity in the presence or absence of TLR4 (Gribar et al., 
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2009). In wild type mice, NEC severity was between 2 and 3 (severe), but in TLR4-mutant 
mice, NEC severity was nearly 0 (normal) (Leaphart et al., 2007). Interestingly, levels of 
TLR4 expression in the gut increase prior to birth and do not decrease to a normal level until 
the day of birth (Gribar et al., 2009), which could partly explain the primary development of 
NEC in preterm infants. Similarly, Lotz et al. (2006) noted rapid TLR4 signaling after LPS 
stimulation in fetal intestinal epithelial cells (IECs) that was completely absent from adult 
IECs. Claud et al. (2004) observed significantly higher pro-inflammatory cytokine secretion 
in response to bacterial infection in immature IECs compared with mature IECs, likely due 
to the increased TLR4 activity in immature enterocytes.
Repair of the injured epithelial layer requires the efficient migration of epithelial cells into 
the site of injury. TLR4 activation increases the adhesion of enterocytes to the underlying 
matrix, which in turn restricts normal cell migration. For example, in a scrape wound assay 
of intestinal epithelial cells, migration was normal under control conditions but significantly 
impaired in the presence of LPS (Leaphart et al., 2007). TLR4 activation inhibits enterocyte 
proliferation (Sodhi et al., 2010), which is a process that is also needed for normal injury 
repair. These observations suggest that TLR4 activation contributes to intestinal injury and 
also inhibits healing (Leaphart et al., 2007; Qureshi et al., 2005; Afrazi et al., 2011).
Although several harmful effects of TLR4 have been identified related to cell migration and 
the inflammatory response, the majority of infants express TLR4 but do not develop NEC. 
When expressed at a normal level, TLR4 signaling plays an important role in establishing 
optimal proliferation and protection against apoptosis in the colon (Afrazi et al., 2011; Sodhi 
et al., 2011). It has been hypothesized that the connection between TLR4 and the 
development of intestinal inflammation is influenced by multiple factors, including the type 
of effector cells, developmental factors, and region of the intestine (Afrazi et al., 2011). 
Moreover, TLR4 signaling has been shown to protect against pathogenic infections as well 
as to induce tolerant responses to commensal bacteria (Kubinak and Round, 2012). Thus, the 
means by which TLR4 responsiveness is maintained at an appropriate level to maintain 
homeostasis and host protection is an important topic for both experimental and 
computational investigation.
TLR9 is a Toll-like receptor that recognizes demethylated DNA, which is DNA that contains 
several CpG motifs (regions of DNA where a cytosine nucleotide occurs next to a guanine 
nucleotide, separated by only one phosphate). These motifs are characteristic of the bacterial 
genome and hence serve to alert the host to the presence of bacterial infection. Studies have 
shown that TLR9 activation with CpG DNA can limit TLR4 signaling in enterocytes and 
reduce intestinal inflammation in NEC (Gribar et al., 2009; Sodhi et al., 2011), unlike the 
activation of inflammation by TLR9 in other contexts. Interestingly, TLR9 and TLR4 are 
reciprocally expressed in the developing intestine (Gribar et al., 2009). That is, when TLR4 
levels are high (pre-birth), TLR9 levels are very low, whereas at birth TLR9 levels are 
elevated and TLR4 levels are low.
Gribar et al. (2009)
 explored the potentially beneficial effects of altering the expression of 
TLR4 and TLR9 in the infant intestine. CpG DNA attenuated TLR4 signaling in enterocytes 
(but not in inflammatory cells), and the amount of bacterial translocation to mesenteric 
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lymph nodes decreased significantly when CpG DNA was added to intestinal epithelial cells 
treated with LPS. Moreover, activation of TLR9 by CpG DNA reduced the severity of 
experimental NEC (Gribar et al., 2009). These observations suggest that promoting the 
activation of TLR9 may be a strategy for treating infants with NEC. It is hypothesized that 
probiotics (nonpathogenic bacteria species that are beneficial to the host and are the same 
species that comprise the normal flora of the gut and breast milk) may be a successful 
treatment for NEC in part because probiotic bacterial DNA can activate TLR9, which in turn 
inhibits the activation of TLR4. Another potential beneficial mechanism of probiotics 
involves their interference with the activation of NF-κB in gut epithelial cells. In particular, 
commensal bacteria (and probiotics) have been shown to inhibit the translocation of NF-κB 
into the nucleus, thereby blocking the release of pro-inflammatory cytokines (Xavier and 
Podolsky, 2000; Neish et al., 2000).
1.4. Computational model
The transfer of nutrients, growth factors, and immunoglobulins from mother to child, which 
would normally protect the infant from bacteria that colonize the intestinal tract, is 
interrupted in infants born prematurely (Edde et al., 2001). As a result, these premature 
infants often experience sustained inflammation and bacterial translocation, which can lead 
to severe diseases. The majority of premature infants never progress to NEC, although up to 
15% of all low birth weight, premature infants have been shown to develop NEC (Lin et al., 
2008b). Mathematical models (Arciero et al., 2010; Reynolds et al., 2006; Kim et al., 2012) 
combined with experimental observations (Gribar et al., 2009; Hackam et al., 2005) can be 
used to investigate potential physiological mechanisms and developmental factors that 
contribute to NEC and to identify possible treatment strategies for the disease. Importantly, 
these models are designed to include factors that may contribute to the pathophysiology of 
NEC, but they predict a wide range of health and disease states that are consistent with the 
clinical observation that NEC often does not develop even among its most susceptible 
population in the majority of cases. A previous theoretical model was focused on predicting 
and understanding the factors that contribute to NEC (Kim et al., 2012); the focus of the 
current study is to evaluate components of the inflammatory response that may impact the 
development of NEC. In particular, the model presented in this study is used to predict 
conditions under which TLR4 and TLR9 activation affect health or disease outcomes for a 
premature infant. The model represents the interactions between a bacterial population and 
certain major elements of the immune response in the mucus layer and intestinal tissue. We 
consider several levels of model complexity, sequentially adding components to identify how 
they contribute to long-term outcomes.
2. Methods
2.1. Model development
A system of ordinary differential equations is used to track the number of bacteria in the 
mucus layer of the intestine and in a combined blood/tissue compartment, the rate of 
bacterial translocation from intestine to blood/tissue, and the effects of macrophage 
activation and inflammation, which are provoked by bacteria. The present model is based on 
our previously published work (Arciero et al., 2010). Our prior mathematical model was 
Arciero et al. Page 6
J Theor Biol. Author manuscript; available in PMC 2016 June 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
altered to include immune mechanisms in the mucus layer that help to limit direct contact 
between bacteria and the epithelium (Hooper and Macpherson, 2010; Lan et al., 2005) as 
well as mechanisms for the activation and interaction of enterocyte TLR4 and TLR9. The 
focus of our study is the investigation of TLR effects on the combined mucus/blood/tissue 
system in the context of NEC. In a departure from our previous model (Arciero et al., 2010), 
an intestinal lumen compartment is not explicitly included in this model; instead, bacteria 
are assumed to enter the mucus layer from the lumen at a fixed rate. Also, the population of 
inflammatory cells tracked in Arciero et al. (2010) is replaced by a pro-inflammatory 
cytokine population in this study. This simplification of considering the immune response as 
a lumped response is sufficient for the purposes of this model but could be altered in the 
future to include more detailed interactions between immune cells and cytokines. A 
schematic illustration of the model compartments and quantities tracked in the model is 
given in Fig. 1A, and model dynamics are depicted in Fig. 1B.
2.1.1. Mucus layer compartment—The dynamics of the number of bacteria in the 
mucus layer (BM) is described by Eq. (1)
(1)
According to this equation, bacteria enter the mucus layer from the intestinal lumen at a 
constant rate BM,source (Duerkop et al., 2009). Increasing this parameter value in Eq. (1) 
signifies an increase in bacteria in the system and can be used to simulate differing degrees 
of infection. Using a constant positive value for BM,source is reasonable since bacteria are 
always present in the mucus. A larger value of BM,source could be used to represent ischemic 
injury, which is typical at least in some animal models of NEC and causes the mucus layer 
to be permissive to bacteria.
Dendritic cells sample the contents of the mucus layer and are effective at killing 
phagocytosed bacteria (Smith et al., 2005; Hooper and Macpherson, 2010) at a rate that we 
treat as saturating, based on the finite size of the dendritic cell population. In the second term 
of Eq. (1), we combine this effect with the destruction of bacteria in the mucus layer by 
antimicrobial proteins; for example, after an E. coli infection was induced in rat intestine, 
bacterial translocation into the blood and liver was significantly lower in rats given 
lactoferrin (an antimicrobial protein present in mother’s milk) than in control-treated rats 
(Edde et al., 2001). We note that the amount of mRNA coding for antimicrobial proteins 
increases with development stage, with the least amount in the fetus and the highest amount 
in the adult (Hecht, 1999). This observation clearly contributes to the susceptibility of 
premature infants to NEC. The parameter value used for kAD in this model is smaller than 
the value that would be used in a corresponding adult model of intestinal interactions.
TLR4 molecules respond directly to LPS. We do not explicitly track LPS in the model, but 
the third term in Eq. (1) represents the effects of TLR4 activation by LPS on mucus layer 
bacteria. Specifically, if activated TLR4 molecules (represented by variable RE in the model) 
sense bacteria (LPS) in the mucus layer, the TLR4 molecules trigger the release of 
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antimicrobial substances into the mucus to destroy bacteria. A saturated form for this term is 
chosen to reflect the limited ability of TLR4 to trigger this antimicrobial release.
Some bacteria are able to penetrate the mucus and enter the blood and tissue by crossing the 
epithelial layer (Deitch, 1994), as has been observed in both animal (Wenzl et al., 2001) and 
human studies (Papoff et al., 2012; Deitch, 1989). The rate of translocation is given by 
variable ε, which appears in the fourth term in Eq. (1). The rate of bacterial translocation 
across the epithelial layer tends to be higher in premature infants due to incomplete 
development of the epithelium as well as damage to the layer caused by an exaggerated 
inflammatory response, as we discuss next.
2.1.2. Epithelial cell layer—The rate of bacterial translocation, ε, evolves according to 
Eq. (2)
(2)
A nonzero rate of translocation (ε0) is specified for the intestinal epithelium under baseline 
conditions (first term), as in Arciero et al. (2010). If the intestinal epithelium is injured, the 
bacteria are able to breach the epithelial barrier more easily (Samel et al., 2002). Bacterial 
translocation across the epithelium initiates a full-blown immune response, which can cause 
additional damage to the epithelial layer and promote a positive feedback cycle between 
inflammation and damage. The risk factors for bacterial translocation are also risk factors for 
NEC, especially an impaired epithelial barrier. To assess how bacterial translocation 
contributes to the pathogenesis of NEC, the model includes a simplified representation of the 
effects of inflammation on bacterial translocation. Specifically, the rate of translocation in 
the model is increased in the presence of blood/tissue pro-inflammatory cytokines, P, with a 
gain f, since cytokines initiate and sustain an inflammatory response that damages the 
intestinal epithelium (Edelson et al., 1999; Bianchi and Manfredi, 2009). Although 
antiinflammatory cytokines are not explicitly included in this model, parameter f is also 
assumed to take into account the inhibitory action of anti-inflammatory cytokines.
Activated TLR4 molecules (RE) and TLR9 molecules (IE) on the epithelium are represented 
in the model using Eqs. (3) and (4)
(3)
(4)
The ligands recognized by TLRs are not specific to pathogenic bacteria, and thus commensal 
bacteria may also activate TLRs (Rakoff-Nahoum et al., 2004). The first and second terms of 
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Eq. (3) represent TLR4 activation in the presence of bacteria (LPS) and pro-inflammatory 
cytokines, respectively. Specifically, term 1 of Eq. (3) defines the activation of a constant, 
inactive TLR4 population, TI, by BM. Blood/tissue pro-inflammatory cytokines, P, can 
trigger signaling processes that may affect TLR4 expression (term 2). Enterocyte TLR9 
molecules (denoted by IE) appear in the denominator of these terms to encode the inhibitory 
effect of TLR9 on TLR4 activation. An ongoing decay of activated TLR4 molecules is also 
assumed (third term).
The method by which TLR9 (IE) is activated has been debated in the literature (Ivory et al., 
2008; Hackam et al., 2005), and thus two methods of TLR9 activation are included in the 
model (Eq. (4)). Specifically, TLR9 molecules may be activated intracellularly once bacteria 
have been internalized by TLR4 (first term) or extracellularly in the presence of bacteria in 
the mucus layer (second term). In term 2, α11 is small, and so we use a linear term to 
approximate a saturating term. A natural decay of these receptors is also assumed (term 3).
2.1.3. Blood/tissue compartment—Eq. (5) gives the rate of change of bacteria in the 
blood/tissue compartment (B)
(5)
A numerical threshold T, which was introduced in a previous model (Arciero et al., 2010), is 
used in the first term of Eq. (5) to represent the translocation of bacteria across the 
epithelium into the blood/tissue as well as the effects of intestinal macrophages, which are 
not explicitly tracked in the model. The threshold term included here is identical to that used 
previously (Arciero et al., 2010)
(6)
that is, bacteria in the mucus are assumed to be internalized only once the product of BM and 
ε exceeds a certain threshold value (given by parameter T) (Hooper and Macpherson, 2010). 
If the product does not exceed the threshold, the bacteria that exit the mucus layer are 
assumed to be eliminated in the epithelium by intestinal macrophages and prevented from 
entering the blood compartment. Although separate populations for pathogenic and 
commensal bacterial species are not defined in this model as they were in Arciero et al. 
(2010)
, the use of a threshold function takes into account that the continuous exposure of the 
epithelium to commensal bacteria in the mucus layer does not trigger a destructive immune 
response. Experimental observations by Han et al. (2004) provide support for using a 
threshold function since bacterial translocation behaved like a step function, remaining 
negligible over a wide range of bacterial population sizes before becoming significant at 
large population levels. Intestinal macrophages do not produce pro-inflammatory cytokines 
(Smythies et al., 2005; Lotz et al., 2006; Smith et al., 2005), and thus an inflammatory 
response is not evoked by this mechanism and a simple representation of intestinal 
macrophage effects is reasonable. If the threshold T is exceeded, then bacteria enter the 
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blood and are eliminated by blood macrophages (here assumed to be proportional to pro-
inflammatory cytokines, P) at rate k5 (second term in Eq. (5)).
Note that alternative, smooth functional forms of the threshold term could be chosen to 
achieve the same effect. For example, using (εBM − T)/(1 − e−β(εBM − T)) in place of [εBM − 
T]+ gives the same qualitative results. We used the latter function so that the model can 
generate solutions in which no bacteria enter the blood/tissue compartment, which makes it 
easy to classify aseptic outcomes. If the max function (Eq. (6)) were not used, then a very 
small amount of bacteria would always enter the blood/tissue compartment, and we would 
lose this unambiguous differentiation between aseptic and septic outcomes.
Blood cytokine levels are typically elevated in infants suffering from NEC, and it is 
hypothesized that studying the pattern of cytokine expression will yield important insights 
into the pathophysiology of the disease (Edelson et al., 1999; Harris et al., 1994). The rate of 
change of pro-inflammatory cytokines in the blood/tissue compartment is given by Eq. (7)
(7)
Pro-inflammatory cytokine production is activated by bacteria in the blood (first term in Eq. 
(7)) (Haller et al., 2000; Lan et al., 2005; Gribar et al., 2009; Ivory et al., 2008). A TLR4 
threshold, TRE, is introduced in the second term of Eq. (7), using the max function (Eq. (6)). 
If the number of TLR4 molecules that are activated exceeds TRE, then a full inflammatory 
response is triggered, leading to cytokine production (Akira et al., 2001; Lotz et al., 2006; 
Edelson et al., 1999; Smith et al., 2005). If the level of activated TLR4 molecules is below 
TRE, then [RE − TRE]+ = 0, such that TLR4 molecules sense bacteria in the mucus and 
antimicrobial protein production is triggered, but an overly robust inflammatory response 
does not ensue. A natural decay of cytokines is also assumed (third term in Eq. (7)).
2.2. Experimental procedure
2.2.1. TLR4 and TLR9 staining in IEC6 and RAW cells—IEC6 enterocytes and RAW 
macrophages (a mouse leukaemic monocyte macrophage cell line commonly used for in 
vitro work studying macrophage biology) were plated upon glass coverslips. Enterocytes 
were treated with LPS (50 µg/ml) and CpG (4 µM) either separately or simultaneously, and 
TLR4 and TLR9 expression were subsequently assessed, at 4, 8, and 16 h. Cells were 
stained for both TLR4 and TLR9 via immunofluroesence. Briefly, cells were fixed in 4% 
Paraformaldehyde for 20 min followed by 20 min in 0.1% Triton-X solution. Non-specific 
binding was blocked with 1% BSA 0.15 M Glycine 5% donkey serum for 1 h. Cells were 
stained with primary antibodies for TLR4 and TLR9 (Imgenex) at 1:100 for 1 h. Cells were 
washed 3 × with PBS and treated with fluorescent secondary antibodies for detection. 
Stained coverslips were imaged on a Zeiss LSM 710 confocal microscope to perform 
imaging using Zen 2009 software.
2.2.2. PCR analysis—IEC6 enterocytes and RAW macrophages were plated upon glass 
coverslips. Enterocytes were treated with either LPS (50 µg/ml) and CpG (4 µM) separately 
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or simultaneously at various timepoints between 4 and 16 h. Cells were harvested and 
subjected to RNA isolation using a RNeasy RNA isolation kit (Qiagen). cDNA transcripts 
were made via Reverse Transcriptase kits (Qiagen). RT-PCR analysis was performed using 
an iQ5 CFX96 Real-time system Thermocycler (Bio-Rad). The primers that were utilized 
are listed in Table 1, where F denotes the forward sequence and R denotes the reverse 
sequence. Multiple comparison procedures were conducted on the PCR data using one-way 
ANOVA followed by Dunn’s post hoc test.
2.3. Parameter values
The model parameters represent rates and relative magnitudes of different types of 
interactions of bacteria with TLR4, TLR9, and inflammatory cells. Values for several 
parameters, including ε0, εmax, k5, τ, and f, were taken directly from related earlier works 
(Arciero et al., 2010; Reynolds et al., 2006). Other parameter values were varied over a wide 
range to assess different behaviors that can be generated by the model. Since this study aims 
to explore the range of biologically feasible outcomes of the immune response to lumenal 
bacteria rather than to fit a specific data sample, an optimization procedure is not used to 
select a specific set of parameter values. However, our results are biologically relevant 
because the mechanisms included in the model are all directly based on experimental and 
clinical observations. Table 2 provides a list of parameter values, units, and descriptions for 
the model, given by Eqs. (1)–(7).
3. Results
Experimental studies have identified TLR4 as a significant factor contributing to the 
pathogenesis of NEC (Gribar et al., 2009; Sodhi et al., 2010; Afrazi et al., 2011). 
Specifically, TLR4 activation leads to increased death of epithelial cells, reduced capacity 
for intestinal cell migration and proliferation, and increased inflammation. The deleterious 
effects of TLR4 have been shown to be dampened by the activation of TLR9 (Gribar et al., 
2009; Afrazi et al., 2011; Leaphart et al., 2007). In this study, the time course of TLR4 
expression was measured in lysates of IEC6 cells in the presence or absence of LPS and 
CpG DNA. TLR4 is the main receptor for LPS, and TLR9 is the main receptor for CpG 
DNA. The enterocytes are not from an immature cell line, but, based on this data and 
additional experimental evidence (Sodhi et al., 2012; Gribar et al., 2009; Liu et al., 2009), 
we hypothesize that the relationships observed here will also apply to, and perhaps be more 
pronounced in, immature enterocytes. The asterisk above the 16 h data in Fig. 2 is used to 
indicate that there is a significant difference between TLR4 expression in the presence of 
LPS at 16 h and TLR4 expression in the presence of LPS + CpG at 16 h (p < 0.05), 
identifying an inhibitory effect of TLR9. In addition, at 16 h, the TLR4 LPS + CpG 
expression level is not significantly different from media (control). Overall, the experimental 
data provide evidence for the increased TLR4 expression in the presence of LPS and the 
decreased expression of TLR4 due to the inhibitory effects of CpG DNA (TLR9).
With these studies and observations as motivation, we used our computational model to 
elucidate the specific contributions of TLR4 and TLR9 to the dynamics of quantities 
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relevant to NEC and to the long-term steady states achieved. As outlined in Fig. 3, the model 
was used to investigate the range of possible outcomes in the following three cases:
1. no TLR4, no TLR9;
2. with TLR4, no TLR9;
3. with TLR4, with TLR9.
In this study, an outcome is defined as healthy if no bacteria are present in the blood (B = 0 
× 106 cells/g) and if the rate of bacterial translocation is at its baseline value (ε = ε0) at 
steady state. To be consistent with existing literature, we classify disease states as aseptic 
death or septic death (Reynolds et al., 2006; Arciero et al., 2010). An aseptic death outcome 
corresponds to no bacteria in the blood (B = 0 × 106 cells/g) but an elevated rate of bacterial 
translocation at steady state (ε > ε0), implying sustained inflammation. Increased 
inflammation, and hence an increased rate of bacterial translocation (above baseline), may 
occur due to increased TLR4 activation; despite this, bacteria will not successfully enter the 
blood/tissue compartment if the threshold (T) is not exceeded, often due to the elimination 
of bacteria that breach the epithelial barrier by intestinal macrophages. Septic death is 
defined as a steady state with bacteria present in the blood (B > 0 × 106 cells/g). Although 
the exact relation between model predictions and clinical diagnoses is not established here, 
model predictions of aseptic and septic death may roughly represent beginning stages of 
NEC and full-blown cases of NEC, respectively. As indicated in Fig. 3, health or disease can 
emerge in the model due to the effects of TLR4, and the additional inclusion of TLR9 can 
push the system toward health or disease depending on the balance of model components. 
The conditions that determine the steady state behavior of the model will be explored across 
these three cases.
3.1. Case 1: absence of both TLR4 and TLR9
In the absence of TLR4 (RE) and TLR9 (IE), the model includes killing of mucus layer 
bacteria by dendritic cells, bacterial translocation from the mucus layer to the blood/tissue if 
the combined mucus layer bacterial population and epithelial permeability becomes 
sufficiently large, and a pro-inflammatory response to the presence of bacteria in the blood/
tissue, which eliminates bacteria but also increases epithelial permeability. To assess the 
contributions of TLR4 and TLR9 to system dynamics, it is useful to first see how this 
reduced system behaves. With RE and IE pinned at 0, the model simplifies to a system of 
four differential equations, corresponding to the NEC model in an earlier work (Arciero et 
al., 2010). The system can be further reduced to two ODEs, for BM and ε, if we make a 
quasi-steady state approximation and set P and B to be functions of εBM that satisfy dB/dt = 
dP/dt = 0. This reduction does not alter the number and values of the equilibria, but it could 
alter their stability (we note that it does not in fact alter the stability here).
The resulting nullclines for BM and ε are shown in Fig. 4. To generate the ε nullcline, we 
consider two components. For one component, we have ε = ε0, P = 0, and B = 0. These 
conditions indeed give dB/dt = dP/dt = dε/dt = 0 as long as ε0BM < T, so this component is 
defined for BM ∈ [0,T/ε0). The other component corresponds to ε > ε0 with P, B > 0, which 
requires εBM > T. The number and location of intersections of the ε and BM nullclines (i.e., 
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critical points) depend on the model parameter values. Here, the effects of BM,source, 
representing the intensity of the bacterial invasion, and kAD, encoding the effectiveness of 
the dendritic cell response, are examined. In each panel of Fig. 4, the dashed black curve 
corresponds to εBM = T. Three possible dynamics for Case 1 are depicted in Fig. 4: a single 
healthy steady state, bistable steady states, or a single disease steady state. Each of these 
cases arises over a range of BM,source and kAD values.
In the first column (Fig. 4A and D), the BM nullcline (blue) intersects the ε nullcline (red) at 
one point along the line ε = ε0. This steady state is healthy since the rate of bacterial 
translocation at steady state is at its baseline value (ε = ε0) and the intersection point of the 
nullclines is located to the left of (below) the dashed black curve, indicating that εBM < T at 
steady state, as needed for consistency. This configuration and an associated stable health 
state are predicted to arise for 0 × 106 cells/g/h ≤ BM,source ≤ 1.65 × 106 cells/g/h (when kAD 
= 1 × 106 cells/g/h). The BM nullcline plotted in Fig. 4A and D depicts the largest value of 
BM,source (to within 0.01 × 106 cells/g/h) within that range. The shaded region in panel A 
corresponds to shifted positions of the BM nullcline that would still yield health.
The second column of Fig. 4 (Fig. 4B and E) illustrates a configuration, which occurs for 
values of BM,source in the range 1.66 × 106 cells/g/h ≤ BM,source ≤ 1.74 × 106 cells/g/h (with 
kAD = 1 × 106 cells/g/h), that yields a prediction of bistability, as indicated by the three 
intersection points of the nullclines. Two BM nullclines (blue), one for BM,source = 1.66 × 
106 cells/g/h and the other for BM,source = 1.74 × 106 cells/g/h, are shown in Fig. 4B to 
outline the region where BM nullclines that give bistability may lie. In this region (shaded), 
the prediction of a health or septic death outcome depends on the initial value of BM. For 
example, for values of BM,source in this range, if BM(0) = 0 × 106 cells/g, health is predicted, 
but if BM(0) = 20 × 106 cells/g, a disease steady state is predicted. Note that intersection 
points on ε = ε0 lie to the left of/below the curve εBM = T, while intersections with ε > ε0 lie 
to the right of/above this curve, such that all are self-consistent.
Finally, in the third column (Fig. 4C and F), the single intersection point corresponds to a 
septic death prediction when BM,source ≥ 1.75 × 106 cells/g/h (kAD = 1 × 106 cells/g/h). In 
this shaded region, the BM nullcline will always intersect the upper branch of the ε nullcline 
once, corresponding to an elevated rate of bacterial translocation (ε > ε0) and presence of 
bacteria in the blood (εBM > T). The second row of Fig. 4 provides a zoomed version of the 
graphs in the top row to depict how the system behavior for the three ranges of BM,source 
results from the shape and location of the nullclines with respect to the threshold curve.
In Case 1, septic death is predicted when the threshold T is exceeded, implying either BM or 
ε has increased sufficiently for their product to exceed and remain above threshold at steady 
state. The parameter values chosen for BM,source, kAD, or kPM affect whether or not this 
threshold is crossed. If the rate of entrance of bacteria into the mucus layer, BM,source, is 
increased (as would occur with the introduction of an infection), the BM nullcline shifts to 
the right and steady states may be created through a saddle-node bifurcation to yield 
bistability (Fig. 4B) or may merge through a subsequent saddle-node bifurcation to ensure 
septic death (Fig. 4C).
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A decrease in kAD will also cause the BM nullcline to shift to the right. A low value of kAD 
corresponds to a weak response by dendritic cells, causing bacterial levels in the mucus 
layer to remain high. The effects of varying BM,source or kAD are summarized with three 
sample nullclines in the ε − BM phase plane in Fig. 5A. Health and disease predictions are 
summarized in kAD−BM,source parameter space in Fig. 5B. The two curves in Fig. 5B 
separate health and septic death regions for initial conditions of BM(0) = 0 × 106 cells/g 
(blue) and BM(0) = 20 × 106 cells/g (magenta). Points to the left of each curve are 
combinations of parameter values for which the corresponding initial condition yields a 
healthy steady state outcome, whereas for points to the right of each curve, this initial 
condition gives a septic death outcome. The points in between the two curves correspond to 
the region of bistability, since health is predicted for BM(0) = 0 × 106 cells/g but septic death 
is predicted for BM(0) = 20 × 106 cells/g in this region.
Increasing kPM corresponds to an immune system that is increasingly sensitive to bacteria in 
the blood. As kPM is increased, the ε nullcline shifts upward and changes shape, causing the 
number of steady states to increase from one to three. Two ε nullclines corresponding to 
increasing values of kPM are shown in the phaseplane in Fig. 5C. While a strong immune 
response is often thought to be beneficial, it also causes increased damage to the epithelial 
layer. Thus, increased sensitivity of the immune response can transform a system from a 
potentially healthy state to a disease state. Fig. 5D gives a summary of health, aseptic death, 
and septic death predictions in the kPM − BM,source parameter space when BM(0) = 20 × 106 
cells/g. If BM(0) = 0 × 106 cells/g, increasing kPM does not change the steady state 
prediction of health for the parameter ranges shown in the figure, and thus this case is not 
depicted in Fig. 5D.
3.2. Case 2: presence of TLR4 and absence of TLR9
Since TLR4 has been shown to be a key contributor to NEC (Gribar et al., 2009; Hackam et 
al., 2005; Sodhi et al., 2010), the previous NEC model in Arciero et al. (2010) is extended to 
include several mechanisms by which TLR4 (RE, see Eq. (3)) acts. To isolate the effects of 
TLR4 in the system that are independent of TLR9, we set IE = 0, and the model reduces to a 
system of five differential equations (Eqs. (1)–(5)).
As in Case 1, all of the model equations in Case 2 can be expressed at steady state in terms 
of BM and ε. The BM nullcline and ε nullcline can be used to assess changes in the possible 
steady states of the model, as illustrated in Fig. 6 (color-coding as in Fig. 4). The nullclines 
shown in Fig. 6A correspond to the case when neither threshold is crossed (i.e., εBM < T and 
RE < TRE), and a healthy steady state is predicted. Note that although the TRE threshold 
cannot be explicitly depicted in the ε − BM phase plane, we use direct simulations of the 
model to determine whether or not TRE has been crossed.
In the center panel (Fig. 6B), the slope of the ε nullcline is positive, and the nullclines 
intersect at a point at which ε > ε0. This indicates that there is sustained inflammation in the 
system, which occurs because RE > TRE. Since the εBM product (at steady state) is to the left 
of the black dashed curve, this panel depicts an aseptic death prediction: no bacteria remain 
in the blood at steady state but ε > ε0. The curves depicted in panels A and B were generated 
under the assumption εBM < T, and a portion of the ε nullcline is colored grey in each to 
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illustrate a region that is inconsistent with this assumption. In Fig. 6C, both thresholds are 
exceeded and a septic death outcome is predicted regardless of BM(0).
The results in Fig. 6 were generated using a single kAD value (kAD = 1 × 106 cells/g/h); in 
Fig. 7, parameters kAD, BM,source, and a1 are varied to determine their effects on model 
predictions in the presence of TLR4. Parameter kAD is the rate at which dendritic cells and 
antimicrobial proteins destroy bacteria in the mucus layer. This parameter is varied since the 
success of this immune response may vary with developmental stage. Parameter BM,source is 
varied to reflect differing degrees of infection. In Fig. 7A, increasing BM,source (or 
decreasing kAD) causes a rightward shift in the BM nullcline and a simultaneous upward 
shift of the ε nullcline. Moderate increases in BM,source cause an increased inflammatory 
response such that RE exceeds the TRE threshold, leading to an aseptic death prediction. 
Significant increases in BM,source cause εBM to increase above T due to both increased 
inflammation and bacteria entering the mucus layer; once T is exceeded, septic death is 
predicted by the model. A summary of health, aseptic, and septic death predictions is shown 
in Fig. 7B in kAD − BM,source parameter space. The results from Case 1 are also provided 
(blue) to illustrate that the health region predicted in the absence of TLR4 shrinks 
substantially and that the previously healthy parameter sets yield aseptic outcomes when the 
roles of TLR4 are considered (Case 2). As in Fig. 5B, regions to the left and right of the 
curves are labeled as health, aseptic, or septic.
The results in Fig. 7A–B are given for a fixed activation rate of TLR4 (a1 = 0.1/h). However, 
these outcomes are sensitive to variations in the rate of bacterial activation of TLR4 (a1). 
Fig. 7C shows the upward shift in the ε nullcline as a1 is increased (BM,source = 1.6 × 106 
cells/g/h). The ε nullcline saturates near εmax = 0.21/h as a1 is increased, demonstrating that 
uncontrolled activation of TLR4 leads to overwhelming inflammation, which is a 
characteristic of NEC. The kAD −BM,source parameter space in Fig. 7D includes the effect of 
increasing a1 (a1 = 0.1/h (green) and 0.5/h (magenta)). The blue curve included in the figure 
shows the division between health and septic death when TLR4 is absent (Case 1). The point 
labeled A represents combinations of parameter values that would yield a healthy outcome 
in Case 1 but an aseptic outcome for Case 2. Point B corresponds to a case that was septic 
for Case 1 and aseptic in Case 2. Interestingly, increasing a1 significantly impacts 
predictions of health by converting a large previously healthy parameter region into an 
aseptic region due to its effect of increasing inflammation in the system. However, 
increasing a1 only weakly affects the boundary between aseptic and septic states, converting 
some borderline aseptic parameter sets to septic outcomes by yielding increased epithelial 
damage and associated bacterial translocation into the blood.
3.3. Case 3: presence of both TLR4 and TLR9
In Case 2, the effects of TLR4 but not TLR9 were included; as a result, the model tended to 
evolve toward disease outcomes, with a possibility of septic death and especially aseptic 
death due to uncontrolled inflammation. Several control mechanisms exist to prevent such 
tendencies from emerging under most circumstances. The action of enterocyte TLR9 is an 
example of such a control mechanism. In intestinal epithelial cells, it has been observed that 
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the activation of TLR9 leads to the inhibition or dampening of TLR4 signaling (Sodhi et al., 
2011).
In Case 3, the full model of six differential equations (Eqs. (1)–(7)) is used to simulate the 
interactions among bacteria, TLR4, TLR9, and the immune response. The effects of 
parameters BM,source, kAD, and a1 on BM and ε nullcline positions are similar to Cases 1 and 
2; the overall effects of these parameters are summarized in Figs. 8 and 9.
In Fig. 8A, the kAD − BM,source parameter space is divided into health, aseptic, and septic 
regions by curves representing Case 1 (blue), Case 2 (red), and Case 3 (black) with a1 = 
0.1/h. Simulating the model in the presence of both TLR4 and TLR9 transforms the 
previously aseptic region predicted in Case 2 to an entirely healthy region. In fact, even a 
small portion of the septic region predicted in Case 2 is predicted to be healthy when both 
TLR4 and TLR9 are included in the model (Case 3). This panel highlights the role of TLR9 
in promoting homeostasis in a normal system, since TLR9 restores health in cases that were 
aseptic (points A and B) or septic (point C) in its absence.
In panels 8B–D, the time series for εBM, ε, and RE are shown for the parameter values that 
correspond to point B in Fig. 8A. Note that the combination of parameter values for point B 
correspond to septic death in Case 1, aseptic death in Case 2, and health in Case 3. In Fig. 
8B, the time course of εBM is shown relative to a dotted line that indicates the threshold 
value T = 1.1 × 106 cells/g/h; in Fig. 8D, the time course of RE is shown relative to a dotted 
line that indicates the TLR4 threshold value TRE = 0.65[RE].
In Fig. 8B, the blue curve (Case 1) remains above the dotted T line, indicating that T is 
exceeded even at steady state and that bacteria are able to enter the blood. Permeability is 
also predicted to remain elevated for Case 1 (panel C). These combined results indicate a 
model prediction of septic death. TLR4 is absent in this case, and thus the blue curve 
corresponding to RE is omitted in panel D. The red curves in these panels correspond to 
Case 2, with TLR4 present but TLR9 absent. In Fig. 8B, we see that εBM < T and thus 
bacteria do not enter the blood/tissue. As observed in Fig. 8D, RE > TRE, which leads to 
increased inflammation, as evidenced by the elevated value of ε in panel C. From these 
panels, we observe that TLR4 molecules are able to keep BM in check and keep εBM below 
T, but since P > 0, ε > ε0 and an aseptic death steady state is predicted.
The black curves in Fig. 8B–D represent Case 3, which includes both TLR4 and TLR9. In 
this case, TLR9 reins in TLR4 (and thus P) such that εBM remains below T (Fig. 8B). As a 
result, B remains lower than it was previously and thus, after an elevated transient, RE falls 
below TRE (Fig. 8D). Since neither threshold is exceeded at steady state, bacteria are not 
present in the blood and ε = ε0. This example shows that the addition of TLR9 brings the 
levels of activated TLR4 below the TRE threshold, thereby reducing overall inflammation in 
the system and restoring health. A summary of the steady state outcomes at all three points 
labeled in Fig. 8A is provided in Table 3.
The a1 − BM,source parameter space in Fig. 9 is divided into health, aseptic, and septic 
regions for Case 1 (blue), Case 2 (red), and Case 3 (black). The blue curve is vertical since 
TLR4 is absent in Case 1, and thus the resulting reduced model does not depend on a1. The 
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harmful effects of TLR4 are evident, particularly at high levels of TLR4 activation (high a1) 
when a significant portion of the original health region (Case 1) is converted to aseptic death 
outcomes. Interestingly, for low a1 values, there are regions of predicted septic death for 
Case 1 that become healthy in Case 2, even without TLR9, indicating an important role for 
TLR4 that was not obvious without running simulations in the presence and absence of the 
receptor. The addition of TLR9 (Case 3) reduces the degree of inflammation caused by 
TLR4 and expands the region where health is predicted. Even the inclusion of TLR9, 
however, cannot restore health in a part of the parameter region made aseptic by TLR4. 
Indeed, we see that even if parameters can be tuned so that the combined presence of TLR4 
and TLR9 can be beneficial (e.g., a1 = 0.1/h), there may be other parameter tunings such that 
their negative effects dominate (e.g., a1 ≥ 0.2/h), pointing to a possible mechanism for how 
an overactive TLR system can promote the emergence of NEC.
When both TLR4 and TLR9 are included in the model, TLR9 generally has beneficial 
effects; however, Point A in Fig. 9A represents an example of a situation in which the effects 
of TLR9 can be harmful (see also Fig. 10, where the same point is labeled, and especially 
Fig. 10B, which provides a zoomed view of the transition curves). Specifically, at Point A, 
the system is healthy in the presence of TLR4 (Case 2) but septic if TLR9 is included (Case 
3). As can be seen more clearly from the temporal dynamics shown in Fig. 9B–D, this 
transition occurs when TLR9 inhibits TLR4 just enough so that the level of bacteria in the 
mucus becomes sufficiently high to cause the product of ε and BM to exceed threshold (T). 
Bacteria can then enter the blood and invoke an immune response, causing RE to increase 
above TRE in Case 3; however, in this parameter regime, the TLR4 response in the presence 
of TLR9 is insufficient to combat the bacteria, and sepsis results.
The parameter space from Fig. 9A is duplicated in Fig. 10 and supplemented with an 
additional curve (green) that illustrates the effect of increasing kIE, which is a key parameter 
promoting TLR9 activation. Increasing kIE could correspond to administering a probiotic 
therapy or drug that favors TLR9 activation over TLR4 since probiotics are composed of a 
DNA sequence that is recognized by TLR9 receptors. Promoting TLR9 activation can 
restore aseptic regions to health (Cases 2 and 3) and also achieve healthy outcomes in a 
portion of the previously septic regions. The inset in panel B is included to highlight several 
parameter regimes in which the inclusion of TLR4, the inclusion of TLR4 and TLR9, or the 
enhancement of TLR9 via increased kIE can lead to interesting effects. These outcomes are 
summarized in Table 4. Importantly, the correct balance of activation and inhibition of 
receptors and immune responses is necessary to maintain homeostasis and protect the host 
against infection, but this balance may depend on the severity of the bacterial invasion.
4. Discussion
TLR4 signaling contributes to the development of NEC by triggering increased 
inflammation and blocking processes such as proliferation and cell migration that are needed 
to repair the damaged epithelial layer (Sodhi et al., 2010; Leaphart et al., 2007). A model 
system of six ordinary differential equations is used in this study to simulate interactions 
among bacteria in the mucus layer, bacteria in the blood, the rate of bacterial translocation 
across the epithelium, pro-inflammatory cytokines, enterocyte TLR4, and enterocyte TLR9, 
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with the goal of identifying how these interactions shape long-term health or disease 
outcomes. The data obtained in this study (Fig. 2) combined with additional experimental 
observations (Gribar et al., 2009; Sodhi et al., 2012) provide evidence for the central 
assumption underlying this model: an increase in TLR4 expression due to the presence of 
LPS can be attenuated by the response of TLR9 molecules to CpG DNA. While these data 
provide insight into the necessary mechanisms to include in a computational model, little 
data are available that would allow us to specify quantitative values for model parameters; 
therefore, we investigate the effects of varying several key parameters, building up from a 
model lacking TLR4 and TLR9, to a model including TLR4 alone, to a model with both 
types of TLR molecules included, to allow for the elucidation of specific contributions of 
each. Model results demonstrate a sensitive interplay among mucus layer dynamics, the 
severity of infection, and TLR activation. In particular, we showed how the relative 
promotion of health and disease by the combined TLR effects in the model depends on the 
rate of TLR4 activation by mucus layer bacteria. We also uncovered parameter regimes 
exhibiting unexpected outcomes, such as a direct promotion of health by TLR4 alone and 
the conversion of a state that is septic with TLR4 present into a healthy state by the inclusion 
of TLR9, which might not have been easily identified in an experimental setting. Fig. 3 gives 
a general summary of our findings, illustrating that TLR4 itself can promote health or 
disease, while the additional inclusion of TLR9 can promote health in place of disease, 
convert healthy states to disease, or maintain outcomes that occurred in its absence, 
depending on the balance of effects in the model.
Previous studies have established both deleterious and protective roles for TLR4 in the 
intestine (Sodhi et al., 2011). Our model is consistent with these observations, and its 
predictions of health or death are largely dependent on parameter values. For example, there 
are values of parameter a1 (the parameter governing TLR4 activation) for which the presence 
of TLR4 alone can expand the health region and the additional inclusion of TLR9 further 
expands the predicted region of health. However, for large values of a1, an aseptic death 
outcome may be predicted despite the combined effects of TLR4 and TLR9. We hypothesize 
that these effects of parameter values on system behavior could relate to the developmental 
status of the neonate in the context of NEC. For example, final maturation in the womb may 
bring about a balance of parameters that yields a healthy outcome whereas premature birth 
may correspond to a case of imbalanced parameters resulting in aseptic death despite the 
inhibitory effects of TLR9 on TLR4.
A “NEC scare” condition almost always precedes full-blown NEC and occurs if an infant’s 
bowel is suspected to be damaged. “NEC scare” infants or any infant that presents symptoms 
of NEC are managed with fluid resuscitation, total parenteral nutrition, bowel rest, and 
intravenous antibiotics (Petty and Ziegler, 2005). In many cases, there is no lasting damage 
to the bowel and no further treatment is needed. Although “NEC scare” is not explicitly 
addressed or defined in terms of model predictions, perhaps the point at which the threshold 
for bacterial translocation is first exceeded could be interpreted as the point at which an 
infant is expressing symptoms of “NEC scare”.
In full-blown cases of NEC, current therapy includes surgical resection of the necrotic area 
combined with supportive care for the infant (Guner et al., 2009) and is inadequate in many 
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cases. Since surgical intervention for NEC is a very invasive procedure with a high rate of 
morbidity, computational studies can be used to explore possible effects of potential 
inflammation-modulating treatments for NEC. Here, several possible interventions are 
discussed in terms of key parameters affecting the system: reducing bacteria population in 
the lumen and mucus layer (parameter BM,source), administering probiotic treatment or CpG 
DNA (parameter kIE), and blocking TLR4 activation (parameter a1). The model predicts that 
these interventions would be successful at restoring health in previously aseptic or septic 
steady state cases under most circumstances. However, the model is also used to show 
situations in which these interventions are not successful; a summary of these scenarios is 
provided in Table 5 and described in detail below for all three model cases considered. As a 
brief example, as stated in Table 5, the proposed treatment of decreasing BM,source would not 
be successful in Case 2 if a1 is too high since inflammation becomes too high and aseptic 
death is predicted (justified by Fig. 7D). The results in Table 5 highlight the concept that 
testing of treatment strategies across multiple conditions is crucial when evaluating their 
potential effects.
4.1. Reducing bacterial population in lumen and mucus layer
Not surprisingly, in model Cases 1, 2, and 3, a decrease in the rate at which bacteria enter 
the mucus layer (defined here by parameter BM,source) will almost always restore health. 
This effect can be seen, for example, from Figs. 7B and 8A, in which a decrease in the 
parameter BM,source causes any point in kAD−BM,source parameter space to enter the healthy 
steady state region. However, there are important exceptions to consider. For example, 
values of parameters kPM and a1 can affect the health predictions in Case 1 and 2, 
respectively. If the rate of pro-inflammatory cytokine production due to blood/tissue bacteria 
condition (kPM, Fig. 5D) or the rate of TLR4 activation by mucosal bacteria bowel is 
suspected to be damaged. (a1, Fig. 7D) is elevated sufficiently, then BM,source must be 
extremely small to achieve a health outcome. It should be noted that BM,source = 0 is not 
possible since there is always some degree of bacteria residing in the intestinal lumen after 
birth. While a low value of BM,source could correspond to treatment with antibiotics, 
antibiotics have not demonstrated efficacy in NEC since they increase TLR4 activation upon 
destroying bacterial components.
An intervention that could boost the host’s ability to recognize and destroy foreign bacteria 
in the mucus layer (i.e., an increase in parameter kAD) would have a similar effect on the 
system as decreasing BM,source (see Figs. 5A and 7A). Such an intervention may correspond 
to administering supplemental IgA. The low incidence of NEC among breastfed infants 
could relate to the immune bolstering effects of breast milk, whereas infants fed formula 
would be modeled using systems with lower kAD values.
4.2. Administering probiotic treatment
Probiotic treatment in the context of NEC has been modeled previously (Arciero et al., 
2010), and the effects of probiotics on NEC have been investigated in several experimental 
and clinical settings (Bin-Nun et al., 2005; Dani et al., 2002; Lin et al., 2008a; Fernandez-
Carrocera et al., 2012; Mihatsch et al., 2012; Wang et al., 2012). Model predictions and 
experimental results have suggested that probiotics can decrease the incidence of NEC in the 
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majority of cases but may trigger sepsis in a few situations. While these observations are 
encouraging, there is still insufficient evidence to recommend probiotics as a routine 
treatment for NEC (Mihatsch et al., 2012). Thus, the efficacy and safety of probiotics as a 
treatment for NEC should continue to be a subject of further study (AlFaleh et al., 2011), 
ideally with help from computational models.
Probiotic bacterial species often out-compete pathogenic bacteria in the lumen and help to 
restore the integrity of the epithelial barrier. Bacterial species contain a sequence of 
unmethylated DNA that is recognized differently from mammalian DNA; as a result, 
bacteria are identified and bound to certain receptors in the gut, such as TLR9 receptors, 
which in turn can inhibit TLR4. The effects of treatment with probiotics in Cases 1 and 2 
would be similar to the effects of decreasing BM,source, since probiotics are assumed to 
compete with pathogenic bacteria and decrease the rate at which bacteria enter the mucus 
layer. In Case 3, treatment with probiotics would also correspond to increasing parameter 
kIE, since probiotics promote the activation of TLR9. As shown in Fig. 10, an increase in kIE 
greatly increases the region of predicted health. However, in some instances, the model 
predicts that previously healthy cases become septic once kIE is increased, demonstrating 
that probiotic treatments may be harmful in some cases. Point B in Fig. 10B represents an 
example of this outcome, where sufficient activation of TLR4 is required to keep BM in 
check and thereby maintain εBM < T and B = 0. An increase in a1 could be used to boost 
TLR4 activation, but care would be needed to ensure that TLR9 activation is increased 
correspondingly to avoid aseptic death (e.g., switch from black to green in Fig. 10A). 
Although the conjectures about probiotics offered in this study do not specify probiotic type, 
it is important to note that different species of probiotics may have different effects in NEC. 
In addition, these probiotic effects most likely differ according to dosage, as observed in 
many clinical studies (Bin-Nun et al., 2005) and predicted by a previous mathematical 
model (Arciero et al., 2010). An important next step in utilizing this model will be the 
translation of the parameter values and regimes investigated mathematically into 
experimental and clinical terms to identify patient-specific cases in which probiotics should 
not be used as a treatment.
4.3. Blocking TLR4 activation
Experimental animal models have shown a significant reduction in the incidence of NEC 
when TLR4 is blocked; thus, administering an agent to block TLR4 activation is a potential 
therapeutic intervention for NEC. In the present model, TLR4 inhibition would correspond 
to decreasing the parameter a1 to weaken TLR4 activation by mucosal bacteria. In Cases 2 
and 3, a reduction in a1 can convert an aseptic death outcome into a health steady state in 
many cases (Fig. 9). However, for larger BM,source, the effects of altering a1 are more subtle. 
For some values ofBM,source, reductions in a1 can restore health in previously septic states 
since limiting inflammation preserves epithelial integrity and the corresponding influx of 
bacteria into the blood/tissue. With further reductions of a1, however, sepsis still results (e.g., 
near point A in Fig. 9A), due to an insufficient ability to eliminate bacteria. This effect may 
relate to the reason that TLR4 has been conserved evolutionarily and been thought to play a 
protective role in non-newborn states (Afrazi et al., 2011). Finally, for some levels of 
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infection (corresponding to very high BM,source), septic death is predicted regardless of 
whether or not TLR4 is blocked.
4.4. Concluding remarks
Tables 3–5 and Fig. 10 show the importance of obtaining an appropriate balance among the 
various immune response defense mechanisms. For example, preventing excessive entry of 
bacteria into the mucus layer is necessary to avoid an overly robust inflammatory response 
to commensal bacteria. Given the presence of mucus layer bacteria, bacterial destruction by 
intestinal macrophages (represented by the threshold T in the model) is also necessary to 
prevent bacteria from entering the intestinal tissue or systemic circulation. Finally, the body 
must be able to respond in an adequately robust, appropriate fashion to infections when the 
epithelial barrier is breached. However, the degree of inflammation must be regulated so that 
the body does not enter a continually inflamed, self-maintaining state (Vodovotz et al., 2008, 
2009; An et al., 2012); in terms of our model, activated TLR4 must decrease below TRE at 
some point in time to achieve a healthy outcome. The model presented in this study is used 
to describe cases in which these immune mechanisms work at an appropriate or 
inappropriate level, leading to various outcomes for the system. As part of this description, 
we have highlighted roles of particular system components in achieving healthy outcomes 
and ways that they can become unbalanced, resulting in detrimental effects.
Some of the regions predicted in the model are small and perhaps difficult to realize since 
they represent a very specific combination of parameter values. However, NEC is a disease 
that only affects a very small percentage of the premature infant population and thus, the 
question of what dictates whether an infant develops NEC may be related to the regimes 
identified in the model. More tightly linking model parameters to specific biological effects 
and using additional experiments to constrain the values of these parameters would be useful 
in undertaking a more quantitative investigation of the mechanisms that give rise to NEC.
Intestinal macrophages are an important mechanism of defense by which the immune 
system responds to an invading pathogen. As described earlier, instead of explicitly tracking 
the population of macrophages in the enterocyte in this model, we set a numerical threshold 
to take into account their effects on bacterial translocation from lumen to blood/tissue. This 
threshold value can be increased or decreased to simulate a system in which intestinal 
macrophages are more or less capable of eliminating bacteria in the mucus layer. 
Experimental studies have identified a different expression and activity of TLR4 and TLR9 
in macrophages than in enterocytes (Gribar et al., 2009); including TLR4 and TLR9 
populations associated with intestinal macrophages in a future model may provide additional 
insight into the pathogenesis of NEC. Expanding the model to include additional 
inflammatory mechanisms and explicit tissue damage may also help to unravel which 
responses or mechanisms contribute most significantly to NEC.
The current model is developed in the context of a premature infant. However, the model 
could be adapted to answer questions about both premature infants and full term infants by 
assigning different parameters to each population. For example, the baseline rate of bacterial 
translocation may be greater in premature infants than full term infants due to the immaturity 
of the intestinal layer. Similarly, the immune response of a premature infant is less selective 
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than that of a full term infant, which also exhibits more mechanisms of negative regulation 
to prevent chronic inflammation. Using and adapting the model to compare these two 
populations may help in better understanding the factors contributing to NEC and other 
chronic intestinal diseases.
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HIGHLIGHTS
► A mathematical model assesses the role of inflammation in 
necrotizing enterocolitis.
► The model demonstrates how bacteria–immune interactions can 
affect health outcomes.
► The model predicts a sensitive interplay between bacteria and 
receptor activation.
► The model identifies unexpected disease outcomes not easily 
detected by experiments.
► The model evaluates whether potential NEC treatment strategies 
could be effective.
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Fig. 1. 
A. Schematic of model (not to scale). B. Interactions of bacteria and the immune response in 
NEC are described using a compartmental model of the small intestine. Bacteria (gray) enter 
the mucus layer where they are recognized by enterocyte TLR4 (labeled) or dendritic cells 
and may be eliminated by antimicrobial proteins (red). Enterocyte TLR9 (labeled) activation 
inhibits TLR4 signaling, whereas enterocyte TLR4 activation triggers TLR9 signaling. 
Bacterial translocation (ε) across the intestinal epithelium (green) occurs via gaps in the 
layer or internalization. Pro-inflammatory cytokine (+) production is triggered in the lumped 
blood/tissue compartment (purple) if bacteria breach the epithelial barrier. The pro-
inflammatory cytokines trigger the elimination of bacteria in the blood but also cause 
damage to the epithelial layer, promoting an increased rate of bacterial translocation. (For 
interpretation of the references to color in this figure caption, the reader is referred to the 
web version of this paper.)
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Fig. 2. 
TLR4 expression on IEC6 enterocytes at 4, 8, and 16 h. All values are compared with 
control state (media, blue). TLR4 expression increases if LPS (red) is added to the system. 
TLR4 expression is decreased in the presence of CpG DNA (black). When both LPS and 
CpG DNA (green) are added to the system, the TLR4 expression decreases with time. The * 
denotes a statistically significant difference in TLR4 expression between LPS and LPS + 
CpG data groups at 16 h (p < 0.05). (For interpretation of the references to color in this 
figure caption, the reader is referred to the web version of this paper.)
Arciero et al. Page 28
J Theor Biol. Author manuscript; available in PMC 2016 June 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Fig. 3. 
Description of the three cases, or levels of model complexity, presented in this work and 
summary of the outcomes that may result. Case 1: no TLR4 and no TLR9 are present in the 
model. Whichever outcome, health or disease, occurs is considered a baseline result, which 
may possibly be modified by the inclusion of TLR4 or TLR4 plus TLR9. Case 2: with TLR4 
but no TLR9. A health state can be achieved if TLR4 activation leads to sufficient bacterial 
killing at the mucus layer level but does not lead to overwhelming inflammation; otherwise, 
a disease state results. Case 3: with TLR4 and with TLR9. Addition of TLR9 helps to lessen 
harmful effects of TLR4, and thus promotes health, in some scenarios, but may suppress its 
positive effects, and thus induce disease, in others.
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Fig. 4. 
Dynamics for Case 1 displayed in the ε−BM phaseplane. RE = IE ≡ 0. Red curves: ε 
nullcline (dε/dt = 0). Blue curves: BM nullcline (dBM/dt = 0). Dotted black curves: εBM = T. 
In each panel, kAD = 1. A. Shaded region corresponds to locations of BM nullcline for 0 × 
106 cells/g/h ≤ BM,source ≤ 1.65 × 106 cells/g/h, such that the BM and ε nullclines intersect at 
a healthy steady state. B. Shaded region corresponds to locations of BM nullcine yielding a 
bistable regime in which a health or disease steady state is predicted depending on BM(0). 
Bistability occurs for 1.66 × 106 cells/g/h ≤ BM,source ≤ 1.74 × 106 cells/g/h. C. Shaded 
region corresponds to locations of BM nullclines yielding a single disease steady state, as 
arises for BM,source ≥ 1.75 × 106 cells/g/h. D–F. Zoomed versions of panels A–C to clearly 
show nullcline and threshold intersections. (For interpretation of the references to color in 
this figure caption, the reader is referred to the web version of this paper.)
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Fig. 5. 
Dynamics for Case 1 as parameters BM,source, kAD, and kPM are varied. A. ε−BM phase 
plane with varied BM,source and kAD. The BM nullcline shifts rightward as BM,source is 
increased or kAD is decreased. This shows that altering the rate of bacterial entry into the 
mucus layer or the rate of bacterial killing by dendritic cells can change the stability of the 
steady state. B. A summary of health and disease steady states are given in kAD−BM,source 
parameter space. Combinations of parameter values to the left of the curves indicate healthy 
steady states and points to the right of the curve are septic death steady states. Two initial 
conditions are shown: BM(0) = 0 × 106 cells/g/h (blue) and BM(0) = 20 × 106 cells/g/h 
(magenta). Bistability is predicted in the region between the blue and magenta curves. C. ε
−BM phase plane with varied kPM. As more pro-inflammatory cytokines are activated (i.e., 
parameter kPM is increased), there is a shift in the ε nullcline and the position and 
classification of equilibrium points. D. Summary of health and disease steady states in the 
kPM−BM,source parameter space for BM(0) = 20 × 106 cells/g/h. The entire parameter space 
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(for the depicted ranges of parameter values) yields a health outcome if BM(0) = 0 × 106 
cells/g/h (not shown). In panels C and D, kAD = 1 × 106 cells/g/h. (For interpretation of the 
references to color in this figure caption, the reader is referred to the web version of this 
paper.)
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Fig. 6. 
Dynamics for Case 2, which includes TLR4 but not TLR9 (i.e., IE ≡ 0), displayed in the ε
−BM phaseplane. Red curves: ε nullcline (dε/dt = 0). Blue curves: BM nullcline (dBM/dt = 
0). Dotted black curves: εBM = T. A. Nullclines are shown for the case when εBM < T and 
RE < TRE. A healthy equilibrium point is predicted. B. Nullclines are shown for εBM < T 
and RE > TRE. An aseptic death steady state is predicted. In panels A and B, the grey portion 
of the ε nullclines indicate regions that are inconsistent with the assumption εBM < T. C. 
Nullclines are shown for the case when εBM > T and RE > TRE. A septic death steady state 
is predicted. (For interpretation of the references to color in this figure caption, the reader is 
referred to the web version of this paper.)
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Fig. 7. 
Dynamics for Case 2, which includes TLR4 but not TLR9, with parameters BM,source, kAD, 
and a1 varied. A. ε−BM phase plane with BM,source or kAD varied. The BM nullcline shifts 
rightward as BM,source is increased or kAD is decreased (with a1 = 0.1/h). The ε nullcline also 
changes shape or slope with changes in BM,source and kAD. B. Summary of health and 
disease steady states in kAD−BM,source parameter space (as in Fig. 5). Summary is provided 
for Case 1 (blue) and Case 2 (green) when a1 = 0.1/h. C. ε−BM phase plane with parameter 
a1 varied (kAD = 1 × 106 cells/g/h and BM,source = 1.6 × 106 cells/g/h). As TLR4 activation 
increases (increase in parameter a1), there is an upward shift of the ε nullcline. D. Summary 
of health and disease steady states are given in kAD−BM,source parameter space for a1 = 0/h 
(blue), 0.1/h (green), and 0.5/h (magenta). Point A is an example of a steady state that is 
predicted to be healthy in Case 1 but that is predicted to be aseptic when the effects of TLR4 
are considered (Case 2). Point B is an example of a septic steady state (Case 1) that becomes 
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aseptic in Case 2. (For interpretation of the references to color in this figure caption, the 
reader is referred to the web version of this paper.)
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Fig. 8. 
Comparison of steady states for Cases 1, 2, and 3. A. Summary of health and disease steady 
states in kAD−BM,source parameter space (as in Fig. 7B) for Case 1 (blue), Case 2 (red), and 
Case 3 (black) when a1 = 0.1/h. The addition of TLR9 to the system (Case 3) restores health 
to regions that were septic and aseptic in Cases 1 and 2. In particular, the entire region of 
parameters yielding aseptic death with TLR4 but without TLR9 becomes healthy when 
TLR9 is included. Three points are labeled to contrast predictions among the three cases: 
point A (BM,source = 1.5 × 106 cells/g/h, kAD = 1.5 × 106 cells/g/h), point B (BM,source = 2.2 
× 106 cells/g/h, kAD = 1.5 × 106 cells/g/h), and point C (BM,source = 2.27 × 106 cells/g/h, 
kAD = 1.5 × 106 cells/g/h). B. εBM versus time t for point B. Three cases are colored as in 
panel A. Dotted line is the value of the εBM threshold, T. C. ε versus time t. Colors as above. 
D. RE (activated TLR4) versus time t. Dotted line is the value of the RE threshold, TRE. 
Colors are as above. (For interpretation of the references to color in this figure caption, the 
reader is referred to the web version of this paper.)
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Fig. 9. 
Summary of health and disease steady states in a1−BM,source parameter space for Case 1 
(blue), Case 2 (red), and Case 3 (black) when kAD = 1. In most of the parameter space, the 
addition of TLR9 (black curves) expands the region of predicted health. Point A, given by 
BM,source = 1.92 × 106 cells/g/h and a1 = 0.02/h, is an example of a situation in which the 
presence of TLR4 alone would restore health to an otherwise septic system, yet the 
additional inclusion of TLR9 hinders the effects of TLR4 and thereby worsens the long-term 
outcome. B–D. Time courses, as in Fig. 8, for parameter values corresponding to point A. 
(For interpretation of the references to color in this figure caption, the reader is referred to 
the web version of this paper.)
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Fig. 10. 
Summary of health and disease steady states in a1−BM,source parameter space, as in Fig. 9A, 
together with an additional curve (green) showing the effect of increasing parameter kIE to 
50 [IE]/h on the predicted steady states. A. Expanded view, with outcomes labeled in 
parameter regions where they occur. B. Zoomed view of the region outlined by dashed black 
lines in A. Labeled points A (BM,source = 1.92 × 106 cells/g/h and a1 = 0.02/h), B (BM,source 
= 1.97 × 106 cells/g/h and a1 = 0.1/h), C (BM,source = 1.95 × 106 cells/g/h and a1 = 0.195/h), 
D (BM,source = 1.6 × 106 cells/g/h and a1 = 0.15/h), and E (BM,source = 2.1 × 106 cells/g/h 
and a1 = 0.15/h) represent several possible effects of TLR4 and TLR9 on observed outcomes 
(see Table 4 for summary).
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Table 1
Primers used to determine effects of TLR4 and TLR9 activation.
Model Primer
mouse TLR4 (F)- GGACTGGGTGAGAAATGAGC
(R)- GCAATGGCTACACCAGGAAT
mouse TLR9 (F)- GCTGGGACGTCTGGTACTGT
(R)- ACCACGAAGGCATCATAAGG
rat TLR4 (F)- TGCTCAGACATGGCAGTTTC
(R)- GCGATACAATTCGACCTGCT
rat TLR9 (F)- CTTCTTTGCTCTGGCGGTAG
(R)- CGTCAGGTTCATCACAATGG
iNOS (F)- CTGCTGGTGGTGACAAGCACATTT
(R)- ATGTCATGAGCAAAGGCGCAGAAC
IL-6 (F)- CCAATTTCCAATGCTCTCCT
(R)- ACCACAGTGAGGAATGTCCA
J Theor Biol. Author manuscript; available in PMC 2016 June 06.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Arciero et al. Page 40
Table 2
Parameter values for NEC model.
Parameter Value Unit Description
BM,source 0–3 106 cells/g/h Rate at which bacteria enter mucus layer
kAD 0–2 106 cells/g/h Maximal rate of bacterial elimination by dendritic cells (DCs)
k3 6 106 cells/g Half saturation of DC bacterial elimination
kAT 0.03 1/h Maximal rate of bacterial elimination by TLR4
αEM 0.18 [RE] Half saturation of TLR4 killing
ε0 0.1 1/h Baseline rate of bacterial translocation Han et al. (2004)
εmax 0.21 1/h Maximum rate of bacterial translocation Han et al. (2004)
τ 24 h Time scale for epithelial repair
f 0.5 1/[P] Strength of effect of inflammation on bacterial translocation (ε)
a1 0–0.5 1/h Maximal rate of activation of TLR4 by bacteria in mucus layer
γ1 5 106 cells/g Half saturation of TLR4 activation by mucosal bacteria (BM)
k1 0.5 [RE]/[P]/h Maximal rate of TLR4 activation by pro-inflammatory cytokines (P)
αRE 2 1/[IE] Strength of inhibitory effect of TLR9 on TLR4 activation by BM and P
μRE 0.1 1/h Decay rate of TLR4
kIE 0–50 [IE]/h Maximal rate of activation of TLR9 by activated TLR4
γIE 10 [RE] Half saturation of TLR9 activation
α11 0.1 [IE]/h Rate of activation of TLR9 directly by bacteria
μIE 1 1/h Decay rate of TLR9
T 1.1 106 cells/g/h Epithelial barrier threshold
k5 25 1/h/[P] Rate of bacterial elimination by cytokines
kPM 0.8 [P]/h Max rate of production of P in response to blood/tissue bacteria (B)
γ12 1.2 106 cells/g Half saturation of P production
kPE 0.002 1/h Maximal rate of production of P by TLR4
TRE 0.65 [RE] Threshold for TLR4 to begin pro-inflammatory cytokine production
γPE 1 1/[IE] Strength of TLR9 inhibition of P production
μ4 0.05 1/h Decay rate of P
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Table 5
Summary of scenarios in which potential treatment strategies for NEC are not successful. Three proposed 
treatments for NEC are listed: reduce bacteria in the mucus layer (decrease BM,source), administer probiotics 
(increase kIE), and block TLR4 (decrease a1). In most cases, the model predicts that all three treatments will 
restore health in previously aseptic or septic cases. However, this provides a summary of scenarios in which 
proposed treatment is not predicted to restore a healthy steady state in each of the mathematical case studies.
Case Decreasing BM,source Increasing kIE Decreasing a1
1 BM(0) high (initially above T) NA NA
2 a1 too high (Fig. 7D) NA BM,source too high; decreased a1 too much (Fig. 9A)
3 a1 too high (Fig. 9A) Specific combination of BM,source and a1 (Fig. 
10A)
BM,source too high; decreased a1 too much (Fig. 9A)
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